Sr Director And Senior Principal Scientist
Genentech, Inc.
Kate Peng is a Director/Principal Scientist in the Department of BioAnalytical Sciences at Genentech. Her group focuses on developing bioanalytical strategies and methods to enable assessment of the pharmacokinetics, immunogenicity, biological activities and protein biomarkers of protein therapeutics from early development to clinical phases as well as post-marketing stages. Kate has led bioanalytical efforts for supporting the development of protein therapeutics that target cancer immunotherapy, immunology, neurology and cardiovascular disease areas. Kate received her Ph.D. from the University of California Berkeley. Prior to joining Genentech in 2007, Kate worked in the biotechnology industry with a focus on developing cell-based methods for high-throughput screening of drug candidates targeting GPCRs.